Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Apr 07, 2021 11:26am
114 Views
Post# 32949256

RE:.60 by friday......

RE:.60 by friday......Clarus has target price of $1.25.  50% increase from here.  Go away.

With this many shorters I feel a squeeze coming.   Diamond hands.


ompong12 wrote: if this selling continous we will be at .60 come friday. big boys are bailing out due to downgrading of clarus. pp last dec 4 can now be sold in the market, 4 months hold is lifted now. so let us all embrace for a selling spree from the big institution holder.

the cc, the late financial reporting, change of direction, acquisition of unknown clinics, roll out to the last minute with no clear marketing plans, cancellation of agm.....all of this are ingredients for a great disaster in stock price. i think this we have some sort of circuit breaker tripp.


<< Previous
Bullboard Posts
Next >>